{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:41:14Z","timestamp":1760550074231,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T00:00:00Z","timestamp":1466121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\\BPD\\98388\\2013","UID\/BIO\/04469\/2013","UID\/BIA\/04050\/2013"],"award-info":[{"award-number":["SFRH\\BPD\\98388\\2013","UID\/BIO\/04469\/2013","UID\/BIA\/04050\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00253-016-7668-4","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T03:14:22Z","timestamp":1466133262000},"page":"9499-9508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Albumin\/asparaginase capsules prepared by ultrasound to retain ammonia"],"prefix":"10.1007","volume":"100","author":[{"given":"Ana","family":"Tinoco","sequence":"first","affiliation":[]},{"given":"Artur","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"C\u00e9sar","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Pier","family":"Parpot","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Gomes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7204-2064","authenticated-orcid":false,"given":"Artur","family":"Cavaco-Paulo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,6,17]]},"reference":[{"key":"7668_CR1","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/leu.2008.165","volume":"22","author":"IM Appel","year":"2008","unstructured":"Appel IM, Kazemier KM, Boos J, Lanvers C, Huijmans J, Veerman AJP, van Wering E, den Boer ML, Pieters R (2008) Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study. Leukemia 22:1665\u20131679","journal-title":"Leukemia"},{"issue":"340","key":"7668_CR2","first-page":"1","volume":"9","author":"E Bahreini","year":"2014","unstructured":"Bahreini E, Aghaiypour K, Abbasalipourkabir R, Mokarram AR (2014) Preparation and nanoencapsulation of L-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study. Nanoscale Res Lett 9(340):1\u201313","journal-title":"Nanoscale Res Lett"},{"key":"7668_CR3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1023\/A:1021125617828","volume":"13","author":"ET Baran","year":"2002","unstructured":"Baran ET, Ozer N, Hasirci V (2002) In vivo half life of nanoencapsulated L-asparaginase. J Mater Sci Mater Med 13:1113\u20131121","journal-title":"J Mater Sci Mater Med"},{"key":"7668_CR4","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.bbrc.2008.10.118","volume":"377","author":"D Cappelletti","year":"2008","unstructured":"Cappelletti D, Chiarelli LR, Pasquetto MV, Stivala S, Valentini G, Scotti C (2008) Helicobacter pylori asparaginase: a promising chemotherapeutic agent. Biochem Biophys Res Commun 377:1222\u20131226","journal-title":"Biochem Biophys Res Commun"},{"key":"7668_CR5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0021-9258(18)62536-0","volume":"246","author":"M Ehrman","year":"1971","unstructured":"Ehrman M, Cedar H, James H (1971) L-asparaginase II of Escherichia coli. J Biol Chem 246:88\u201394","journal-title":"J Biol Chem"},{"key":"7668_CR6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3923\/ijp.2014.182.199","volume":"10","author":"NE El-Naggar","year":"2014","unstructured":"El-Naggar NE, El-Ewasy SM, El-Shweihy NM (2014) Microbial L-asparaginase as a potential therapeutic agent for the treatment of acute lymphoblastic leukemia: the pros and cons. Int J Pharmacol 10:182\u2013199","journal-title":"Int J Pharmacol"},{"key":"7668_CR7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","volume":"157","author":"AO Elzoghby","year":"2012","unstructured":"Elzoghby AO, Samy WM, Elgindy NA (2012a) Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 157:168\u2013182","journal-title":"J Control Release"},{"key":"7668_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2012.04.036","volume":"161","author":"AO Elzoghby","year":"2012","unstructured":"Elzoghby AO, Samy WM, Elgindy NA (2012b) Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release 161:38\u201349","journal-title":"J Control Release"},{"key":"7668_CR9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1517\/14656566.8.12.1977","volume":"8","author":"CH Fu","year":"2007","unstructured":"Fu CH, Sakamoto KM (2007) PEG-asparaginase. Expert Opin Pharmacother 8:1977\u20131984","journal-title":"Expert Opin Pharmacother"},{"key":"7668_CR10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.molcatb.2011.09.009","volume":"74","author":"S Ghosh","year":"2012","unstructured":"Ghosh S, Chaganti SR, Prakasham RS (2012) Polyaniline nanofiber as a novel immobilization matrix for the anti-leukemia enzyme l-asparaginase. J Mol Catal B Enzym 74:132\u2013137","journal-title":"J Mol Catal B Enzym"},{"key":"7668_CR11","first-page":"103","volume":"7","author":"K Heitink-Poll\u00e9","year":"2012","unstructured":"Heitink-Poll\u00e9 K, Prinsen B, Koning T, Hasselt P, Bierings M (2012) High incidence of symptomatic hyperammonemia in children with acute lymphoblastic leukemia receiving pegylated asparaginase. Springer 7:103\u2013108","journal-title":"Springer"},{"key":"7668_CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1470-8744.1997.tb01332.x","volume":"26","author":"J Jean-Fran\u00e7ois","year":"1997","unstructured":"Jean-Fran\u00e7ois J, D\u2019Urso EM, Fortier G (1997) Immobilization of L-asparaginase into a biocompatible poly(ethylene glycol)-albumin hydrogel: evaluation of performance in vivo. Biotechnol Appl Biochem 26:203\u2013212","journal-title":"Biotechnol Appl Biochem"},{"key":"7668_CR13","first-page":"137","volume":"3","author":"DS Kumar","year":"2012","unstructured":"Kumar DS, Sobha K (2012) L-asparaginase from microbes\u202f: a comprehensive review. Adv Biores 3:137\u2013157","journal-title":"Adv Biores"},{"key":"7668_CR14","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1039\/C4RA13802C","volume":"5","author":"A Loureiro","year":"2014","unstructured":"Loureiro A, Abreu AS, S\u00e1rria MP, Figueiredo MCO, Saraiva LM, Bernardes GJL, Gomes AC, Cavaco-Paulo A (2014) Functionalized protein nanoemulsions by incorporation of chemically modified BSA. RSC Adv 5:4976\u20134983","journal-title":"RSC Adv"},{"issue":"5","key":"7668_CR15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.nano.2015.02.022","volume":"11","author":"A Loureiro","year":"2015","unstructured":"Loureiro A, Bernardes GJL, Shimanovich U, S\u00e1rria MP, Nogueira E, Preto A, Gomes AC, Cavaco-Paulo A (2015a) Folic acid-tagged protein nanoemaulsions loaded with CORM-2 enhance the survival of mice bearing subcutaneous A20 lymphoma tumors. Nanomed Nanotechnol Biol Med 11(5):1077\u20131083","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"7668_CR16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.colsurfb.2015.06.073","volume":"135","author":"A Loureiro","year":"2015","unstructured":"Loureiro A, Nogueira E, Azoria NG, Sarria MP, Abreu AS, Shimanovich U, Rollett A, Marmark J, Herbert H, Guebitz G, Bernardes CJ, Preto A, Gomes AC, Cavaco-Paulo A (2015b) Size controlled protein nanoemulsions for active targeting of folate receptor positive cells. Colloids Surf B: Biointerfaces 135:90\u201398","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"7668_CR17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1476-4431.2011.00695.x","volume":"21","author":"SE Lyles","year":"2011","unstructured":"Lyles SE, Kow K, Milner RJ, Buckley GJ, Bandt C, Baxter KJ (2011) Acute hyperammonemia after L-asparaginase administration in a dog. J Vet Emerg Crit Care 21:673\u2013678","journal-title":"J Vet Emerg Crit Care"},{"key":"7668_CR18","first-page":"97","volume":"28","author":"HJ Muller","year":"1998","unstructured":"Muller HJ, Boos J (1998) Use of L-asparaginase in childhood ALL. Oncol Hematol 28:97\u2013113","journal-title":"Oncol Hematol"},{"key":"7668_CR19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/bit.10074","volume":"75","author":"M Nasseau","year":"2001","unstructured":"Nasseau M, Boublik Y, Meier W, Winterhalter M, Fournier D (2001) Substrate-permeable encapsulation of enzymes maintains effective activity, stabilizes against denaturation, and protects against proteolytic degradation. Biotechnol Bioeng 75:615\u2013618","journal-title":"Biotechnol Bioeng"},{"key":"7668_CR20","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1080\/10428190701509822","volume":"48","author":"L Nott","year":"2007","unstructured":"Nott L, Price TJ, Pittman K, Patterson K, Fletcher J (2007) Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy. Leuk Lymphoma 48:1702\u20131711","journal-title":"Leuk Lymphoma"},{"key":"7668_CR21","unstructured":"Nussbaum V, Lubcke N, Findlay R (2014) Hyperammonemia secondary to asparaginase: a case series. J Oncol Pharm Pract 1\u20134"},{"key":"7668_CR22","first-page":"1","volume":"01","author":"M Paulides","year":"2013","unstructured":"Paulides M, Jung R, Chada M, Lausen B, Metzler M, Langer T (2013) Prospective longitudinal examination of hyperammonemia during L-asparaginase treatment within 24\u00a0hours after administration in childhood lymphoblastic malignancies. J Leuk 01:1\u20133","journal-title":"J Leuk"},{"key":"7668_CR23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0003-2697(77)90043-4","volume":"83","author":"GL Peterson","year":"1977","unstructured":"Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346\u2013356","journal-title":"Anal Biochem"},{"key":"7668_CR24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/ics.12065","volume":"35","author":"A Ribeiro","year":"2013","unstructured":"Ribeiro A, Matam\u00e1 T, Cruz CF, Gomes AC, Cavaco-Paulo AM (2013) Potential of human \u03b3D-crystallin for hair damage repair: insights into the mechanical properties and biocompatibility. Int J Cosmet Sci 35:458\u2013466","journal-title":"Int J Cosmet Sci"},{"issue":"Suppl 1","key":"7668_CR25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/CCO.0b013e32835d7d85","volume":"25","author":"C Rizzari","year":"2013","unstructured":"Rizzari C, Conter V, Star\u00fd J, Colombini A, Moericke A, Schrappe M (2013) Optimizing asparaginase therapy for acute lymphoblastic leukemia. Curr Opin Oncol 25(Suppl 1):S1\u2013S9","journal-title":"Curr Opin Oncol"},{"key":"7668_CR26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-3659(98)00148-5","volume":"58","author":"H Sah","year":"1999","unstructured":"Sah H (1999) Stabilization of proteins against methylene chloride\/water interface-induced denaturation and aggregation. J Control Release 58:143\u2013151","journal-title":"J Control Release"},{"key":"7668_CR27","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1021\/mp3001827","volume":"9","author":"R Silva","year":"2012","unstructured":"Silva R, Ferreira H, Azoia NG, Shimanovich U, Freddi G, Gedanken A, Cavaco-Paulo A (2012) Insights on the mechanism of formation of protein microspheres in a biphasic system. Mol Pharm 9:3079\u20133088","journal-title":"Mol Pharm"},{"key":"7668_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6865(99)00009-6","volume":"74","author":"AL Stecher","year":"1999","unstructured":"Stecher AL, De Deus PM, Polikarpov I (1999) Stability of L-asparaginase\u202f: an enzyme used in leukemia treatment. Pharm Acta Helv 74:1\u20139","journal-title":"Pharm Acta Helv"},{"issue":"5","key":"7668_CR29","first-page":"2719","volume":"22","author":"F Suzuki","year":"2002","unstructured":"Suzuki F, Okayasu H, Tashiro M, Hashimoto K, Yokote Y, Akahane K, Hongo S, Sakagami H (2002) Effect of lignins and their precursors on nitric oxide, citrulline and asparagine production by mouse macrophage-like raw 264.7 cells. Anticancer Res 22(5):2719\u20132724","journal-title":"Anticancer Res"},{"key":"7668_CR30","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s10856-008-3684-y","volume":"20","author":"E Teodor","year":"2009","unstructured":"Teodor E, Litescu SC, Lazar V, Somoghi R (2009) Hydrogel-magnetic nanoparticles with immobilized l-asparaginase for biomedical applications. J Mater Sci Mater Med 20:1307\u20131314","journal-title":"J Mater Sci Mater Med"},{"key":"7668_CR31","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1182\/blood-2013-10-534347","volume":"123","author":"WH Tong","year":"2014","unstructured":"Tong WH, Pieters R, Kaspers GJL, Loo DMWM, Bierings MB, van den Bos C, Kollen WJW, Hop WCJ, Lanvers-kaminsky C, Relling MV, Tissing WJE, van der Sluis IM (2014) A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia. Blood 123:2026\u20132034","journal-title":"Blood"},{"key":"7668_CR32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1381-1177(00)00043-6","volume":"11","author":"I Vina","year":"2001","unstructured":"Vina I, Karsakevich A, Bekers M (2001) Stabilization of anti-leukemic enzyme L-asparaginase by immobilization on polysaccharide Levan. J Mol Catal B Enzym 11:551\u2013558","journal-title":"J Mol Catal B Enzym"},{"key":"7668_CR33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2008.07.026","volume":"364","author":"R Wang","year":"2008","unstructured":"Wang R, Xia B, Li BJ, Peng SL, Ding LS, Zhang S (2008) Semi-permeable nanocapsules of konjac glucomannan-chitosan for enzyme immobilization. Int J Pharm 364:102\u2013107","journal-title":"Int J Pharm"},{"key":"7668_CR34","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1182\/blood-2006-09-045351","volume":"109","author":"M Wetzler","year":"2007","unstructured":"Wetzler M, Sanford BL, Kurtzberg J, DeOliveira D, Frankel SR, Powell BL, Kolitz JE, Bloomfield CD, Larson RA (2007) Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: cancer and leukemia group B study 9511. Blood 109:4164\u20134167","journal-title":"Blood"},{"key":"7668_CR35","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1016\/j.biomaterials.2003.10.019","volume":"25","author":"YQ Zhang","year":"2004","unstructured":"Zhang YQ, Tao ML, de Shen W, Zhou YZ, Ding Y, Ma Y, Zhou WL (2004) Immobilization of L-asparaginase on the microparticles of the natural silk sericin protein and its characters. Biomaterials 25:3751\u20133759","journal-title":"Biomaterials"},{"key":"7668_CR36","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1039\/c0sm01332c","volume":"7","author":"Y-Q Zhang","year":"2011","unstructured":"Zhang Y-Q, Wang Y-J, Wang H-Y, Zhu L, Zhou Z-Z (2011) Highly efficient processing of silk fibroin nanoparticle-l-asparaginase bioconjugates and their characterization as a drug delivery system. Soft Matter 7:9728","journal-title":"Soft Matter"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-016-7668-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-016-7668-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-016-7668-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T18:07:19Z","timestamp":1718647639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-016-7668-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,17]]},"references-count":36,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["7668"],"URL":"https:\/\/doi.org\/10.1007\/s00253-016-7668-4","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"type":"print","value":"0175-7598"},{"type":"electronic","value":"1432-0614"}],"subject":[],"published":{"date-parts":[[2016,6,17]]}}}